Related Experiment Video
Updated: Jul 18, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
Published on: August 25, 2012
Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia
H Akyol1, F Sarialioğlu, M Büyükpamukçu
1Division of Pediatric Oncology, Hacettepe Children's Hospital, Ankara, Turkey.
Insights
This case study highlights a rare instance of procarbazine-induced hyperpyrexia in a child undergoing chemotherapy for Hodgkin
Area of Science:
- Pediatric Oncology
- Clinical Pharmacology
Background:
- Hodgkin's disease is a cancer of the lymphatic system.
- Combined chemotherapy regimens, such as COPP, are standard treatment for Hodgkin's disease.
- Adverse drug reactions can complicate cancer treatment, requiring careful monitoring.
Observation:
- A child with Hodgkin's disease, neurofibromatosis, and pectus excavatum developed recurrent high fever during COPP chemotherapy.
- Initial fever episodes were suspected to be infections, but recurred despite antibiotic treatment.
- Hospitalization was required due to persistent hyperpyrexia and arrhythmia, prompting investigation into drug-induced fever.
Findings:
- Procarbazine, a component of the COPP regimen, was identified as the causative agent for hyperpyrexia.
- A test dose of procarbazine triggered a severe febrile reaction with nausea and vomiting.
- This represents the second reported case of procarbazine-induced hyperpyrexia.
Implications:
- Clinicians should consider cytotoxic-induced fever, specifically from procarbazine, in pediatric cancer patients presenting with unexplained hyperpyrexia.
- Careful administration and monitoring of procarbazine are crucial, especially in patients with complex medical histories.
- Prompt recognition and management with antihistamines and steroids can control procarbazine-induced febrile reactions.
Abstract:
A case of hyperpyrexia induced by procarbazine in a child with Hodgkin's disease, neurofibromatosis, and pectus excavatum deformity is presented. After the diagnosis of stage IIIS Hodgkin's disease, combined COPP chemotherapy was initiated. One week later she presented with high fever. After a diagnosis of infection was made, chemotherapy was stopped and antibiotics were given. Nearly the same picture recurred three times after reinstituting chemotherapy. On the fourth occasion, the patient had to be hospitalized because of hyperpyrexia and arrhythmia. There was no obvious reason for fever, and cytotoxic-induced fever was considered. The drugs were given one at a time. When a test dose (10 mg) of procarbazine was given, she developed a high fever with severe nausea and vomiting. The reaction was controlled by antihistaminics and steroids. To our knowledge this is the second report on hyperpyrexia due to procarbazine administration.
More Related Videos
Related Concept Videos
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Types of Fever
Here are the different types of fever:
Patterns of Fever
Hypersensitivity Reactions: Cytolytic Reactions
Drug toxicity: Idiosyncratic Reactions

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)